(19)
(11) EP 4 204 448 A2

(12)

(88) Date of publication A3:
16.06.2022

(43) Date of publication:
05.07.2023 Bulletin 2023/27

(21) Application number: 21769136.9

(22) Date of filing: 27.08.2021
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61K 39/00(2006.01)
C07K 16/28(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/18; C07K 16/28; A61K 39/0011; A61K 2039/6056; C12N 2710/20034; A61P 35/00; C07K 2317/622; C07K 2317/31; C07K 2317/52; C07K 2317/77
(86) International application number:
PCT/EP2021/073781
(87) International publication number:
WO 2022/043517 (03.03.2022 Gazette 2022/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.08.2020 EP 20193168

(71) Applicants:
  • cureab GmbH
    4125 Riehen (CH)
  • Universität Basel Vizerektorat Forschung
    4001 Basel (CH)

(72) Inventors:
  • STENNER-LIEWEN, Frank
    4125 Riehen (CH)
  • MARKULY, Norbert
    5080 Laufenburg (CH)
  • LIEWEN, Heike
    4125 Riehen (CH)
  • LIU, Yang
    5073 Gipf-Oberfrick (CH)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) ANTI-GOLPH2 ANTIBODIES FOR MACROPHAGE AND DENDRITIC CELL DIFFERENTIATION